Kringle Pharma Balance Sheet Health
Financial Health criteria checks 6/6
Kringle Pharma has a total shareholder equity of ¥2.1B and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥2.8B and ¥648.9M respectively.
Key information
0%
Debt to equity ratio
JP¥0
Debt
| Interest coverage ratio | n/a |
| Cash | JP¥2.31b |
| Equity | JP¥2.11b |
| Total liabilities | JP¥648.92m |
| Total assets | JP¥2.76b |
Financial Position Analysis
Short Term Liabilities: 4884's short term assets (¥2.8B) exceed its short term liabilities (¥128.2M).
Long Term Liabilities: 4884's short term assets (¥2.8B) exceed its long term liabilities (¥520.7M).
Debt to Equity History and Analysis
Debt Level: 4884 is debt free.
Reducing Debt: 4884 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4884 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 4884 has sufficient cash runway for 2 years if free cash flow continues to reduce at historical rates of 27.7% each year.